metoprolol has been researched along with Migraine Disorders in 55 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| " For the acute treatment of migraine attacks or tension-type headache, ibuprofen (10 mg per kg body weight) or acetaminophen (15 mg per kg body weight) are recommended with highest evidence, intranasal sumatriptan (10 to 20 mg) can be given as second choice." | 4.81 | [Treatment of idiopathic headache in childhood - recommendations of the German Migraine and Headache Society (DMKG)]. ( Evers, S; Gerber, WD; Naumann, E; Pothmann, R; Uberall, M, 2002) |
| "Propranolol has been most extensively studied and proved effective in 19 of 21 controlled trials." | 3.77 | [Beta-blockers and migraine]. ( Bousser, MG; Massiou, H, 1992) |
| "Vestibular migraine (VM) is the most frequent cause of recurrent spontaneous attacks of vertigo causally related to migraine." | 2.90 | Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG). ( Adrion, C; Al Tawil, A; Bayer, O; Mansmann, U; Strupp, M, 2019) |
| "Beta-blockers are a first choice migraine preventive medication." | 2.84 | The enigma of site of action of migraine preventives: no effect of metoprolol on trigeminal pain processing in patients and healthy controls. ( Hebestreit, JM; May, A, 2017) |
| "Twenty patients suffering from migraine without aura were randomly divided into two groups." | 2.73 | Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study. ( Andrasik, F; Averkina, N; Gerber, WD; Kropp, P; Lindner, V; Niederberger, U; Siniatchkin, M; Stephani, U; Strenge, H, 2007) |
| "Both drugs reduced the number of migraine days per month by 37% (95% confidence interval 21-53%) compared with the placebo run-in period." | 2.67 | Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability. ( Alslev, T; Iversen, H; Kinge, E; Lademann, A; Larsen, BH; Nøhr, P; Pedersen, KK; Rasmussen, MJ; Schrøder, P; Sørensen, PS, 1991) |
| "Nifedipine was of no value in the prophylaxis of migraine." | 2.67 | Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis. ( Diener, HC; Gerber, WD; Niederberger, U; Scholz, E, 1991) |
| "At baseline, migraine patients had significantly higher VEP amplitudes and longer latencies than did a group of 87 healthy control subjects." | 2.66 | Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. ( Bille, A; Dichgans, J; Diener, HC; Gerber, WD; Jäck, A; Niederberger, U; Scholz, E, 1989) |
| "Twelve patients with classical migraine were included." | 2.66 | The difference between non-selective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients. ( Hedman, C; Knudsen, JB; Winther, K, 1986) |
| "Metoprolol was significantly better than placebo with regard to the total frequency of attacks (1." | 2.66 | Classic migraine: effective prophylaxis with metoprolol. ( Andersen, AR; Andersson, PG; Gilhus, NE; Hedman, C; Hultgren, M; Kangasniemi, P; Olesen, J; Vilming, S, 1987) |
| " The dosage of metoprolol was 50 mg b." | 2.66 | Metoprolol v. clonidine in the prophylactic treatment of migraine. ( Hedman, C; Louis, P; Schoenen, J, 1985) |
| " The dosage of pizotifen was 0." | 2.66 | Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation. ( Hedman, C; Standnes, B; Vilming, S, 1985) |
| "Metoprolol was used in a dosage of 50 mg b." | 2.65 | Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study. ( Behring, HC; Forssman, B; Hedman, C; Hedman, G; Johansson, F; Kinnman, J; Olsson, JE; Pålhagen, SE; Samuelsson, M; Strandman, E, 1984) |
| "In a double-blind, cross-over study the effect and tolerance of the non-selective beta-blocker propranolol in a dosage of 80 mg twice daily was compared to that of the beta 1-selective beta-blocker metoprolol 200 mg once daily in Durules (a controlled-release formulation)." | 2.65 | Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study. ( Hedman, C; Kangasniemi, P, 1984) |
| "The treatment of headache is usually successful and thus highly rewarding for physicians of all medical specialties." | 2.58 | Hints on Diagnosing and Treating Headache. ( May, A, 2018) |
| "The improvement of migraine in the patients who recieved propranolol for angina pectoris revealed the effectiveness of propranolol in migraine prophylaxis." | 2.45 | [Beta blockers in migraine prophylaxis]. ( Shimizu, T, 2009) |
| "The treatment of migraine takes into consideration the intensity of the headache and the accompanying symptoms." | 2.42 | [Treatment and prophylaxis of an acute migraine attack]. ( Diener, HC; Gendolla, A, 2004) |
| "Metoprolol(MTP), a migraine preventive with a slow onset of action, was used for comparison." | 1.43 | Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells. ( Dirnagl, U; Hellen, P; Hoffmann, J; Neeb, L; Reuter, U, 2016) |
| "The therapy for chronic migraine with botulinum toxin is now established in adults." | 1.40 | [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology]. ( Bernhard, MK; Bertsche, A; Merkenschlager, A; Syrbe, S; Weise, S, 2014) |
| "Single migraine attacks were treated successfully with triptanes." | 1.33 | Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline. A case report. ( Bickel, A; Kornhuber, J; Maihöfner, C; Ropohl, A, 2005) |
| " Therefore, it is quite possible that both drugs produce adverse immunological effects in vivo in cases of high dosage or obstruction of elimination." | 1.31 | [Effect of migraine medications on monocyte chemotaxis] . ( Krumholz, W; Menges, T; Ogal, H; Szalay, G, 2000) |
| "We followed-up 64 migraine patients after discontinuation of successful interval prophylaxis with flunarizine, propranolol or metoprolol, to investigate how long the therapeutic success would last, if further prophylaxis would be successful again, and what factors would influence the prognosis." | 1.28 | Long-term results of migraine prophylaxis with flunarizine and beta-blockers. ( Koch, G; Wessely, P; Wöber, C; Wöber-Bingöl, C, 1991) |
| "Thirty-three patients with common migraine underwent contingent negative variation (CNV) recordings before receiving prophylactic beta-blocker treatment with either metoprolol (27 patients) or propranolol (6 patients) at mean daily dosages of 110 mg and 122 mg, respectively." | 1.27 | Contingent negative variation and efficacy of beta-blocking agents in migraine. ( Maertens de Noordhout, A; Schoenen, J; Timsit, M; Timsit-Berthier, M, 1986) |
| "The prophylactic treatment of migraine with beta blockers is at present well established, and non-selective as well as beta 1-selective beta blockers exert an effect." | 1.27 | Beta-adrenoceptor blockade, platelets, and rheologic factors. ( Hedman, C; Winther, K, 1986) |
| "beta-Adrenoceptor blockers effective in migraine prophylaxis include propranolol (nonselective) and metoprolol (beta 1-selective), but it is uncertain how beta-receptor subtype selectivity might influence platelet behavior in migraine." | 1.27 | Platelet activity and selective beta-blockade in migraine prophylaxis. ( Clifford Rose, F; Joseph, R; Schultz, LU; Steiner, TJ, 1988) |
| "In the prophylaxis of migraine beta-blockers are commonly used." | 1.27 | Combination headache: practical experience with a combination of a beta-blocker and an antidepressive. ( Kellhammer, U; Pfaffenrath, V; Pöllmann, W, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (47.27) | 18.7374 |
| 1990's | 12 (21.82) | 18.2507 |
| 2000's | 10 (18.18) | 29.6817 |
| 2010's | 7 (12.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayer, O | 1 |
| Adrion, C | 1 |
| Al Tawil, A | 1 |
| Mansmann, U | 1 |
| Strupp, M | 1 |
| Hebestreit, JM | 1 |
| May, A | 2 |
| Bernhard, MK | 1 |
| Bertsche, A | 1 |
| Syrbe, S | 1 |
| Weise, S | 1 |
| Merkenschlager, A | 1 |
| Smelt, AF | 1 |
| Assendelft, WJ | 1 |
| van Dijk, CE | 1 |
| Blom, JW | 1 |
| Neeb, L | 1 |
| Hellen, P | 1 |
| Hoffmann, J | 1 |
| Dirnagl, U | 1 |
| Reuter, U | 1 |
| Shimizu, T | 1 |
| Gerwig, M | 1 |
| Niehaus, L | 1 |
| Stude, P | 1 |
| Katsarava, Z | 1 |
| Diener, HC | 6 |
| Akarachkova, ES | 1 |
| Tabeeva, GR | 1 |
| Volkova, ZI | 1 |
| Dlusskaia, IG | 1 |
| Striuk, RI | 1 |
| Veĭn, AM | 1 |
| Croissant, B | 1 |
| Brosi, K | 1 |
| Hermann, D | 1 |
| Mann, K | 1 |
| Gendolla, A | 1 |
| Bickel, A | 1 |
| Kornhuber, J | 1 |
| Maihöfner, C | 1 |
| Ropohl, A | 1 |
| Siniatchkin, M | 1 |
| Andrasik, F | 1 |
| Kropp, P | 1 |
| Niederberger, U | 3 |
| Strenge, H | 1 |
| Averkina, N | 1 |
| Lindner, V | 1 |
| Stephani, U | 1 |
| Gerber, WD | 6 |
| Schellenberg, R | 1 |
| Lichtenthal, A | 1 |
| Wöhling, H | 1 |
| Graf, C | 1 |
| Brixius, K | 1 |
| Koch-Weser, J | 1 |
| Frishman, WH | 1 |
| Johnson, JM | 1 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Olsson, JE | 2 |
| Behring, HC | 1 |
| Forssman, B | 1 |
| Hedman, C | 11 |
| Hedman, G | 1 |
| Johansson, F | 1 |
| Kinnman, J | 1 |
| Pålhagen, SE | 1 |
| Samuelsson, M | 1 |
| Strandman, E | 2 |
| Kangasniemi, P | 4 |
| Andersson, PG | 3 |
| Dahl, S | 1 |
| Hansen, JH | 1 |
| Hansen, PE | 1 |
| Kristensen, TN | 1 |
| de Fine Olivarius, B | 1 |
| Steardo, L | 1 |
| Bonuso, S | 1 |
| Di Stasio, E | 1 |
| Marano, E | 1 |
| Ljung, O | 2 |
| Kaube, H | 1 |
| Goadsby, PJ | 1 |
| Hesse, J | 1 |
| Møgelvang, B | 1 |
| Simonsen, H | 1 |
| Brune, K | 1 |
| Göbel, H | 1 |
| Pfaffenrath, V | 2 |
| Sartory, G | 1 |
| Müller, B | 1 |
| Metsch, J | 1 |
| Pothmann, R | 2 |
| Krumholz, W | 1 |
| Szalay, G | 1 |
| Ogal, H | 1 |
| Menges, T | 1 |
| Hartung, E | 1 |
| Chrubasik, J | 1 |
| Evers, S | 2 |
| Schoenen, J | 4 |
| Eikermann, A | 1 |
| Latta, G | 1 |
| Hauke, W | 1 |
| Uberall, M | 1 |
| Naumann, E | 1 |
| Wörz, R | 1 |
| Reinhardt-Benmalek, B | 1 |
| Föh, M | 1 |
| Grotemeyer, KH | 4 |
| Scharafinski, HW | 2 |
| Massiou, H | 1 |
| Bousser, MG | 2 |
| Sørensen, PS | 1 |
| Larsen, BH | 1 |
| Rasmussen, MJ | 1 |
| Kinge, E | 1 |
| Iversen, H | 1 |
| Alslev, T | 1 |
| Nøhr, P | 1 |
| Pedersen, KK | 1 |
| Schrøder, P | 1 |
| Lademann, A | 1 |
| Wöber, C | 1 |
| Wöber-Bingöl, C | 1 |
| Koch, G | 1 |
| Wessely, P | 1 |
| Scholz, E | 2 |
| Winther, K | 3 |
| Flodgaard, H | 1 |
| Schlake, HP | 3 |
| Husstedt, IW | 3 |
| Nyrke, T | 1 |
| Lang, AH | 1 |
| Brune, G | 1 |
| Dichgans, J | 1 |
| Jäck, A | 1 |
| Bille, A | 1 |
| Maertens de Noordhout, A | 2 |
| Timsit-Berthier, M | 2 |
| Timsit, M | 2 |
| Tfelt-Hansen, P | 1 |
| Joseph, R | 2 |
| Steiner, TJ | 2 |
| Schultz, LU | 1 |
| Clifford Rose, F | 1 |
| Raveau-Landon, C | 1 |
| Knudsen, JB | 1 |
| Andersen, AR | 2 |
| Gilhus, NE | 2 |
| Nestvold, K | 1 |
| Olesen, J | 2 |
| Rose, FC | 1 |
| Hultgren, M | 1 |
| Vilming, S | 2 |
| Kellhammer, U | 1 |
| Pöllmann, W | 1 |
| Langohr, HD | 1 |
| Koletzki, E | 1 |
| Mayer, K | 1 |
| Schroth, G | 1 |
| Louis, P | 1 |
| Standnes, B | 1 |
8 reviews available for metoprolol and Migraine Disorders
| Article | Year |
|---|---|
Hints on Diagnosing and Treating Headache.
Topics: Amitriptyline; Analgesics, Non-Narcotic; Antihypertensive Agents; Headache; Humans; Metoprolol; Migr | 2018 |
[Beta blockers in migraine prophylaxis].
Topics: Adrenergic beta-Antagonists; Drug Administration Schedule; Humans; Metoprolol; Migraine Disorders; N | 2009 |
[Treatment and prophylaxis of an acute migraine attack].
Topics: Acupuncture Therapy; Acute Disease; Administration, Oral; Adrenergic beta-Antagonists; Analgesics; A | 2004 |
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Me | 1981 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
[Treatment of idiopathic headache in childhood - recommendations of the German Migraine and Headache Society (DMKG)].
Topics: Acetaminophen; Adrenergic beta-Antagonists; Age Factors; Analgesics, Non-Narcotic; Biofeedback, Psyc | 2002 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Pote | 1992 |
27 trials available for metoprolol and Migraine Disorders
| Article | Year |
|---|---|
Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG).
Topics: Adult; Aged; Dizziness; Double-Blind Method; Early Termination of Clinical Trials; Female; Follow-Up | 2019 |
The enigma of site of action of migraine preventives: no effect of metoprolol on trigeminal pain processing in patients and healthy controls.
Topics: Adrenergic beta-Antagonists; Adult; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypothal | 2017 |
Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study.
Topics: Adrenergic beta-Antagonists; Adult; Delayed-Action Preparations; Double-Blind Method; Female; Humans | 2007 |
Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
Topics: Adrenergic beta-Antagonists; Adult; Benzopyrans; Double-Blind Method; Ethanolamines; Evaluation Stud | 2008 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study.
Topics: Adolescent; Adult; Analgesics; Clinical Trials as Topic; Double-Blind Method; Ergotamine; Female; He | 1984 |
Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Hemodynamics; Humans; Long | 1984 |
Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation.
Topics: Acupuncture Therapy; Adult; Aged; Analysis of Variance; Female; Humans; Male; Metoprolol; Middle Age | 1994 |
A comparison of psychological and pharmacological treatment of pediatric migraine.
Topics: Adolescent; Adrenergic beta-Antagonists; Behavior Therapy; Biofeedback, Psychology; Child; Combined | 1998 |
A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study.
Topics: Adolescent; Adult; Aged; Aspirin; Female; Humans; Male; Metoprolol; Middle Aged; Migraine Disorders; | 2001 |
[Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol].
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Double-Blind Method; Female; Humans; Male; Metoprolo | 1992 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Pote | 1992 |
Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability.
Topics: Adult; Double-Blind Method; Female; Flunarizine; Humans; Male; Metoprolol; Middle Aged; Migraine Dis | 1991 |
Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Dose-Response Relationship, Drug; Female; Follow-Up S | 1991 |
Platelet P1, P4-Di (adenosine-51) tetraphosphate (AP4A) in migraine patients before and during beta-adrenoceptor blockade.
Topics: Adenosine Triphosphate; Adult; Blood Platelets; Dinucleoside Phosphates; Female; Humans; Male; Metop | 1990 |
Acetylsalicylic acid vs. metoprolol in migraine prophylaxis--a double-blind cross-over study.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Male; Metoprolol; Migraine Disorders; Recurrenc | 1990 |
Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Evoked Potentials, Visual; Female; Humans; Mal | 1989 |
Efficacy of beta-blockers in migraine. A critical review.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Migr | 1986 |
[Metoprolol, a new effective antimigraine agent].
Topics: Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Humans; Metoprolol; Migraine Disorder | 1988 |
The difference between non-selective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Blood Platelets; Cyclic AMP; Double-Blind Meth | 1986 |
[Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study].
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Flunarizine; Heart Rat | 1988 |
Symptoms of classic migraine attacks: modifications brought about by metoprolol.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Metopr | 1988 |
Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up.
Topics: Adult; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Foll | 1988 |
Classic migraine: effective prophylaxis with metoprolol.
Topics: Adolescent; Adult; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Femal | 1987 |
Clomipramine and metoprolol in migraine prophylaxis--a double-blind crossover study.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Drug Therapy, Combination; Femal | 1985 |
Metoprolol v. clonidine in the prophylactic treatment of migraine.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Clonidine; Double-Blind Method | 1985 |
Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation.
Topics: Adolescent; Adult; Analgesics; Body Weight; Double-Blind Method; Ergotamine; Female; Humans; Male; M | 1985 |
22 other studies available for metoprolol and Migraine Disorders
| Article | Year |
|---|---|
[Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology].
Topics: Adolescent; Adrenergic beta-Antagonists; Botulinum Toxins, Type A; Chronic Disease; Female; Fructose | 2014 |
Triptan use after starting prophylactic migraine treatment: a retrospective cohort study in a primary care population.
Topics: Adult; Analgesics; Cohort Studies; Female; Humans; Male; Metoprolol; Middle Aged; Migraine Disorders | 2014 |
Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Calcitonin Gene-Related Peptide; Cells, Cultured; C | 2016 |
Beta-blocker migraine prophylaxis affects the excitability of the visual cortex as revealed by transcranial magnetic stimulation.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Evoked Potentials, Motor; Female; Humans; Male; Meto | 2012 |
[Clinical significance of adrenoreactivity in patients with some paroxysmal disorders (panic attacks and migraine)].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Citalopram; Diagnostic and Statistical Manual of Men | 2003 |
[Drug-induced headache and pain reduction medication with amitriptyline in an 11-year old pupil].
Topics: Amitriptyline; Analgesics; Antihypertensive Agents; Aspirin; Child; Dipyrone; Headache Disorders; Hu | 2004 |
Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline. A case report.
Topics: Adrenergic beta-Antagonists; Antimanic Agents; Depressive Disorder, Major; Female; Humans; Lithium; | 2005 |
Prophylactic treatment of classical and non-classical migraine with metoprolol--a comparison with placebo.
Topics: Adolescent; Adult; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Migraine Diso | 1983 |
Selective and non-selective beta-blockers: are both effective in prophylaxis of migraine? A clinical trial versus methysergide.
Topics: Adolescent; Adult; Female; Humans; Male; Methysergide; Metoprolol; Middle Aged; Migraine Disorders; | 1982 |
Metoprolol in migraine.
Topics: Adult; Aged; Female; Humans; Male; Metoprolol; Middle Aged; Migraine Disorders; Propanolamines | 1981 |
Treatment of migraine with metoprolol.
Topics: Aged; Female; Humans; Male; Metoprolol; Middle Aged; Migraine Disorders; Propanolamines | 1980 |
Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat.
Topics: Analgesics; Animals; Aspirin; Cats; Cerebral Cortex; Clonazepam; Cortical Spreading Depression; Dihy | 1994 |
[Treatment of migraine attacks and migraine prophylaxis: recommendations of the German Migraine and Headache Society].
Topics: Adult; Analgesics; Antiemetics; Child; Clinical Protocols; Germany; Humans; Metoprolol; Migraine Dis | 1998 |
[Effect of migraine medications on monocyte chemotaxis] .
Topics: Adult; Analgesics; Aspirin; Chemotaxis, Leukocyte; Dihydroergotamine; Humans; Immune Tolerance; Male | 2000 |
Long-term results of migraine prophylaxis with flunarizine and beta-blockers.
Topics: Adult; Aged; Female; Flunarizine; Humans; Male; Metoprolol; Middle Aged; Migraine Disorders; Prognos | 1991 |
Transient asymmetries of steady-state visual evoked potentials in classic migraine.
Topics: Adult; Evoked Potentials, Visual; Female; Functional Laterality; Humans; Male; Metoprolol; Middle Ag | 1990 |
Paired stimulation and functional change of the sural nerve during beta blocker therapy.
Topics: Adrenergic beta-Antagonists; Adult; Electric Stimulation; Female; Humans; Male; Metoprolol; Middle A | 1989 |
Contingent negative variation and efficacy of beta-blocking agents in migraine.
Topics: Adrenergic beta-Antagonists; Adult; Contingent Negative Variation; Electrophysiology; Female; Humans | 1986 |
Beta-adrenoceptor blockade, platelets, and rheologic factors.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic beta-Antagonists; Erythrocytes; Fibrinolysis; Humans; Lipop | 1986 |
Platelet activity and selective beta-blockade in migraine prophylaxis.
Topics: Adenosine Diphosphate; Adolescent; Adrenergic beta-Antagonists; Adult; Blood Platelets; Epinephrine; | 1988 |
Combination headache: practical experience with a combination of a beta-blocker and an antidepressive.
Topics: Adult; Amitriptyline; Cluster Headache; Drug Therapy, Combination; Female; Headache; Humans; Male; M | 1986 |
Effects of beta blockade on contingent negative variation in migraine.
Topics: Adult; Contingent Negative Variation; Electrophysiology; Female; Humans; Male; Metoprolol; Migraine | 1987 |